Current sequencing technology enables generation of whole genome sequencing data sets that contain a high density of rare variants, each of which is carried by, at most, 5% of the sampled subjects. Such variants are involved in the etiology of most common diseases in humans. These diseases can be studied by relevant longitudinal phenotype traits. Tests for association between such genotype information and longitudinal traits allow the study of the function of rare variants in complex human disorders. In this paper, we propose an association-screening framework that highlights the genotypic differences observed on rare variants and the longitudinal nature of phenotypes. In particular, both variants within a gene and longitudinal phenotypes a...
Genome and exome sequencing in large cohorts enables characterization of the role of rare variation ...
Although genome‐wide association studies have been successful in detecting associations with common ...
Advances in high-throughput sequencing technologies are transforming the landscape of biomedical res...
Both common variants and rare variants are involved in the etiology of most complex diseases in huma...
A dual-clustering framework for association screening with whole genome sequencing data and longitud...
Most genome-wide association studies (GWAS) look for correlation between genetic variants and diseas...
[[abstract]]Functional variants are likely to be aggregated in family studies enriched with affected...
Over the past few years, an increasing number of studies have identified rare variants that contribu...
[[abstract]]Given the functional relevance of many rare variants, their identification is frequently...
Case-control genetic sequencing studies are increasingly being conducted to identify rare variants a...
Genetic association studies with longitudinal markers of chronic diseases (e.g., blood pressure, bod...
Next-generation DNA sequencing platforms can effectively detect the entire spectrum of genomic varia...
Access restricted to the OSU CommunityIn this dissertation, we develop statistical methods for analy...
Genome-wide association studies (GWASs) have been largely limited to investigating traits with a sin...
Recent breakthroughs in next-generation sequencing technologies allow cost-effective methods for mea...
Genome and exome sequencing in large cohorts enables characterization of the role of rare variation ...
Although genome‐wide association studies have been successful in detecting associations with common ...
Advances in high-throughput sequencing technologies are transforming the landscape of biomedical res...
Both common variants and rare variants are involved in the etiology of most complex diseases in huma...
A dual-clustering framework for association screening with whole genome sequencing data and longitud...
Most genome-wide association studies (GWAS) look for correlation between genetic variants and diseas...
[[abstract]]Functional variants are likely to be aggregated in family studies enriched with affected...
Over the past few years, an increasing number of studies have identified rare variants that contribu...
[[abstract]]Given the functional relevance of many rare variants, their identification is frequently...
Case-control genetic sequencing studies are increasingly being conducted to identify rare variants a...
Genetic association studies with longitudinal markers of chronic diseases (e.g., blood pressure, bod...
Next-generation DNA sequencing platforms can effectively detect the entire spectrum of genomic varia...
Access restricted to the OSU CommunityIn this dissertation, we develop statistical methods for analy...
Genome-wide association studies (GWASs) have been largely limited to investigating traits with a sin...
Recent breakthroughs in next-generation sequencing technologies allow cost-effective methods for mea...
Genome and exome sequencing in large cohorts enables characterization of the role of rare variation ...
Although genome‐wide association studies have been successful in detecting associations with common ...
Advances in high-throughput sequencing technologies are transforming the landscape of biomedical res...